Pulmatrix PULM
NASDAQ PULM
$1.41 -0.07 (-4.38%)
As of: Sep 10, 2026 · 11:37 AM EDT

Pulmatrix (PULM) Non Operating Interest Expenses (2014 - 2022)

Pulmatrix's (PULM) quarterly Non Operating Interest Expenses came in at $51000.0 in Q2 2022, up 920.0% year-over-year from $5000.0 in Q2 2021, and up 363.64% quarter-over-quarter from $11000.0 in Q1 2022.

Analysis

Pulmatrix (PULM) Non Operating Interest Expenses (2014 - 2022) Analysis & Trends

Pulmatrix has disclosed Non Operating Interest Expenses across 8 years of filings, most recently posting $51000.0 for Q2 2022.

  • In Q2 2022, Non Operating Interest Expenses rose 920.0% year-over-year to $51000.0; the TTM figure through Jun 2022 stood at $89000.0 (down 37.32% YoY), while the FY2021 annual figure was $11000.0, down 95.4% from the prior year.
  • Non Operating Interest Expenses came in at $51000.0 for Q2 2022 at Pulmatrix, up from $11000.0 in the prior quarter.
  • In the past five years, Non Operating Interest Expenses ranged from a high of $106000.0 in Q1 2018 to a low of $5000.0 in Q2 2021.
  • Average Non Operating Interest Expenses over 4 years is $48750.0, with a median of $36500.0 recorded in 2021.
  • Year-over-year, Non Operating Interest Expenses plunged 53.49% in 2018 and soared 920.0% in 2022.
  • Over 4 years, Non Operating Interest Expenses stood at $106000.0 in 2018, then sank by 91.51% to $9000.0 in 2020, then tumbled by 44.44% to $5000.0 in 2021, then soared by 920.0% to $51000.0 in 2022.
  • Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $51000.0 in Q2 2022, $11000.0 in Q1 2022, and $5000.0 in Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 640.32 Bn 619.56 Bn 17.26 Bn 281.00 Mn
2 AbbVie 445.20 Bn 438.64 Bn 12.70 Bn -
3 Merck 357.17 Bn 350.03 Bn 12.21 Bn -
4 Novartis Ag 267.38 Bn 259.69 Bn 11.24 Bn -462.00 Mn
5 Pfizer 156.69 Bn 145.00 Bn 10.94 Bn -
6 Sanofi 52.12 Bn 44.74 Bn 10.79 Bn -333.60 Mn
7 Revolution Medicines 42.92 Bn 42.92 Bn - 23.78 Mn
8 Incyte 24.60 Bn 20.06 Bn 1.57 Bn 582,000.00
9 United Therapeutics 21.29 Bn 18.63 Bn 683.80 Mn 2.90 Mn
10 Pulmatrix 5.17 Mn 5.17 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 51,000.00
Mar 31, 2022 11,000.00
Jun 30, 2021 5,000.00
Mar 31, 2021 22,000.00
Jun 30, 2020 9,000.00
Dec 31, 2018 106,000.00
Jun 30, 2018 80,000.00
Mar 31, 2018 106,000.00
Dec 31, 2017 131,000.00
Sep 30, 2017 153,000.00
Jun 30, 2017 172,000.00
Mar 31, 2017 187,000.00
Dec 31, 2016 208,000.00
Sep 30, 2016 225,000.00
Jun 30, 2016 224,000.00
Mar 31, 2016 223,000.00
Sep 30, 2015 731,000.00
Jun 30, 2015 511,000.00
Mar 31, 2015 184,000.00
Sep 30, 2014 14.75 Mn